Scinai Immunotherapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $467 | $487 | $269 |
Gross Profit | -1,273 | -1,114 | -691 |
EBITDA | -1,586 | -2,008 | -1,531 |
EBIT | -2,182 | -2,460 | -1,889 |
Net Income | -2,037 | 3,567 | -2,086 |
Net Change In Cash | 467 | 487 | 269 |
Free Cash Flow | -2,607 | -1,455 | -1,734 |
Cash | 2,852 | 3,114 | 1,661 |
Basic Shares | 57,002 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,311 | $658 | $0 | $0 |
Gross Profit | -2,652 | -580 | -512 | -559 |
EBITDA | -6,527 | -6,989 | -2,185 | -5,234 |
EBIT | -7,948 | -8,638 | -2,699 | -5,796 |
Net Income | -8,307 | 4,796 | -6,500 | -5,796 |
Net Change In Cash | 1,311 | 658 | 0 | 0 |
Free Cash Flow | -6,055 | -6,347 | -10,019 | -8,101 |
Cash | 1,661 | 1,964 | 4,870 | 14,075 |
Basic Shares | 233 | 80 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.74 |
2026-03-31 | $0.94 |
2025-09-30 | -$24.85 |
2025-06-30 | -$2.60 |